In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $23.91, marking a -0.99% move from the previous day.
Viking enrolls around 280 participants in the phase II study evaluating the oral version of its obesity drug. Data from this ...
The article " Which Healthcare Stock Is the Best Buy Right Now? " first appeared on MarketBeat.
Viking Therapeutics (NasdaqCM:VKTX) has experienced an 11% monthly decline in its stock price, a notable movement amid its recent announcements and a wider market downturn. The company completed the ...
Currently trading with a volume of 1,145,610, the VKTX's price is down by -1.23%, now at $28.0. RSI readings suggest the ...
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $20 ...
One of the great things about equity markets is that you don't need a fortune to get started. Though strong companies that ...
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) saw unusually large options trading on Monday. Stock investors acquired 31,516 call options on the stock. This is an increase of 87% compared ...
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been given a consensus rating of “Buy” by the thirteen research ...